1. Home
  2. MGY vs BLCO Comparison

MGY vs BLCO Comparison

Compare MGY & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGY
  • BLCO
  • Stock Information
  • Founded
  • MGY 2017
  • BLCO 1853
  • Country
  • MGY United States
  • BLCO Canada
  • Employees
  • MGY N/A
  • BLCO N/A
  • Industry
  • MGY Oil & Gas Production
  • BLCO Ophthalmic Goods
  • Sector
  • MGY Energy
  • BLCO Health Care
  • Exchange
  • MGY Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • MGY 4.7B
  • BLCO 4.0B
  • IPO Year
  • MGY 2017
  • BLCO 2022
  • Fundamental
  • Price
  • MGY $22.41
  • BLCO $11.47
  • Analyst Decision
  • MGY Hold
  • BLCO Hold
  • Analyst Count
  • MGY 14
  • BLCO 12
  • Target Price
  • MGY $25.75
  • BLCO $15.59
  • AVG Volume (30 Days)
  • MGY 2.1M
  • BLCO 727.8K
  • Earning Date
  • MGY 07-30-2025
  • BLCO 07-30-2025
  • Dividend Yield
  • MGY 2.65%
  • BLCO N/A
  • EPS Growth
  • MGY 0.57
  • BLCO N/A
  • EPS
  • MGY 2.01
  • BLCO N/A
  • Revenue
  • MGY $1,346,769,000.00
  • BLCO $4,829,000,000.00
  • Revenue This Year
  • MGY $1.15
  • BLCO $6.97
  • Revenue Next Year
  • MGY $3.91
  • BLCO $5.48
  • P/E Ratio
  • MGY $10.92
  • BLCO N/A
  • Revenue Growth
  • MGY 8.79
  • BLCO 11.94
  • 52 Week Low
  • MGY $19.09
  • BLCO $10.45
  • 52 Week High
  • MGY $29.02
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • MGY 54.34
  • BLCO 44.53
  • Support Level
  • MGY $21.40
  • BLCO $10.99
  • Resistance Level
  • MGY $22.37
  • BLCO $12.05
  • Average True Range (ATR)
  • MGY 0.50
  • BLCO 0.40
  • MACD
  • MGY 0.00
  • BLCO 0.07
  • Stochastic Oscillator
  • MGY 56.46
  • BLCO 45.28

About MGY Magnolia Oil & Gas Corporation

Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquid (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area in South Texas, where the Company targets the Eagle Ford Shale and Austin Chalk formations. Its objective is to generate stock market value over the long term through consistent organic production growth, high full-cycle operating margins, and an efficient capital program with short economic paybacks. The company's operating segment is acquisition, development, exploration, and production of oil and natural gas properties located in the United States.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: